1 Min Read
May 1 (Reuters) - miRagen Therapeutics Inc:
* MIRAGEN THERAPEUTICS ANNOUNCES INITIATION OF SECOND PHASE 1 CLINICAL TRIAL OF MRG-110 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.